Taking aspirin regularly may reduce a person’s risk of developing pancreatic cancer in half
Taking aspirin regularly may reduce a person’s risk of developing pancreatic cancer in half—and the degree of protection could increase the longer the aspirin is taken.
Pancreatic cancer is among the deadliest cancers, with the five-year survival rate at less than 5 percent. By the time it is diagnosed, it is usually too late to treat successfully.
For a new study, published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers collected data from a Connecticut population study of 362 newly diagnosed pancreatic cancer patients and a control group of 690 disease-free people. They analyzed associations between risk of pancreatic cancer and past aspirin use.
The study, which took place from 2005 to 2009, looked at regular use of both low-dose aspirin (75 to 325 mg. per day, taken for heart disease prevention) and regular-dose aspirin (325 to 1,200 mg. taken for pain or anti-inflammation purposes).
Overall, both low-dose and regular-dose aspirin reduced the risk for developing pancreatic cancer by half. Significantly, among those who took aspirin for more than 10 years, the risk reduction was even higher—60 percent.
more
http://www.futurity.org/aspirin-can-cut-pancreatic-cancer-risk-much-60-724202/
= new reply since forum marked as read
